Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of IV Ig impact on infections in myeloma pts receiving daratumumab finds all-grade infxns were 43% lower, G3-4 infections were 70% lower compared to observation periods (no IVIG use), indicating substantial benefit.”
Title: Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab
Authors: Guido Lancman, Dahniel Sastow, Minira Aslanova, Erin Moshier, Hearn Jay Cho, Sundar Jagannath, Samir Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Santiago Thibaud, Ajai Chari
You can read the Full Article in Haematologica.
You can find other articles featuring Robert Orlowski on OncoDaily.
